Global biotech industry, of which large-scale industrialization process is just beginning, is estimated to grow rapidly by 2020 and become world’s leading industry. As Chinese strategic industry in the 21st century, it is still in its early stage.
Three major clusters of comprehensive biological industry parks were established in the Yangtze River Delta, Pearl River Delta and Beijing-Tianjin-Hebei region. China also constructed biotechnology specialized high-tech parks in northeast region and central and western region. So far, this spatial distribution pattern of biological industry in China is yielding initial magnet effect. Build-up effect promotes the biotech enterprises, investments, technologies and talents to congregate toward the area which have advantages and form the arrangement of central and local government and finance facilitating biotech industry, to strongly derive innovation ability of biotech and speed up the commercialization of scientific and technological findings.
Recently, DM Intelligence Ltd. presented 2019 BIO international convention. The BIO International Convention, which hosted by the Biotechnology Innovation Organization (BIO), is the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
DM Intelligence Ltd. delivered a speech and presented Artificial Intelligence Drug Discovery Platform, following with exchanging experience and ideas.
China is an important player in the biotechnology, and it has great potential to lessen the gap with the leading biotech nation in the world.